Concepedia

Livingstone Fultang

LF

Statistics

Publications

8

Citations

576

H-Index

8

Active since

2018

Affiliations

University of Birmingham(Current)

Cancer Research UK Clinical Trials Unit

University of Glasgow

Genomics (United Kingdom)

International Network for Cancer Treatment and Research

Livingstone Fultang is an author at University of Birmingham specializing in oncology, immunology, and life sciences.

ORCID

Publications per year

2018–2024

8

Publications

8

Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity

Livingstone Fultang, Sarah Booth, Orli Yogev et al. · Blood · 2020 · 178 citations · Full text

, , +14

MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers

Livingstone Fultang, Silvia Panetti, Margaret H.L. Ng et al. · EBioMedicine · 2019 · 164 citations · Full text

, , +17

Targeting the arginine metabolic brake enhances immunotherapy for leukaemia

Francis Mussai, Rachel Wheat, Evgenia Sarrou et al. · International Journal of Cancer · 2018 · 81 citations · Full text

, , +17

Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma

Livingstone Fultang, Laura D. Gamble, Luciana Gneo et al. · Cancer Research · 2018 · 67 citations · Full text

, , +9

Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment

Silvia Panetti, Nicola McJannett, Livingstone Fultang et al. · Blood Advances · 2022 · 46 citations · Full text

, , +16

1–5 of 8